CliffBio
small molecule

BREZTRI AEROSPHERE

BUDESONIDE; FORMOTEROL FUMARATE; GLYCOPYRROLATE

Loss of exclusivityOctober 2038latest FDA-listed patent expiry
CompanyASTRAZENECA AB

Drug detail

Brand nameBREZTRI AEROSPHERE
Active ingredientBUDESONIDE; FORMOTEROL FUMARATE; GLYCOPYRROLATE
Strength0.16MG/INH;0.0048MG/INH;0.009MG/INH
Dosage formAEROSOL, METERED
RouteINHALATION
ModalitySmall molecule
FDA approvalJuly 2020
Marketing statusRX

Listed patents

PatentExpiresType
11833292October 2038product
11331442October 2038product
8815258March 2031use U-2889
9463161May 2030product
8703806May 2030use U-2889
8324266May 2030use U-2889
8808713May 2030product
9415009May 2030use U-2889
10716753May 2030product

More from ASTRAZENECA AB

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.